Widely used:Recently Viewed
Clear AllQuality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$14 Mln
P/E Ratio
0.01
P/B Ratio
2.92
Industry P/E
--
Debt to Equity
0.19
ROE
0.58 %
ROCE
-17.69 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$2.44 Mln
EBITDA
$-2.05 Mln
Net Profit
$-20.65 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
China SXT Pharmaceuticals - ADR
| 309.37 | -20.91 | 388.49 | 103.92 | -24.72 | -43.83 | -- |
|
BSE Sensex*
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2021
|
2020
|
|
|---|---|---|---|
|
China SXT Pharmaceuticals - ADR
| -70.70 | -50.61 | -59.88 |
|
S&P Small-Cap 600
| 13.89 | 25.27 | 9.57 |
|
BSE Sensex
| 18.74 | 21.99 | 15.75 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products,... and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China. Address: 178 North Taidong Road, Taizhou, China, 225300 Read more
Chairman of the Board & CEO
Mr. Feng Zhou
Chairman of the Board & CEO
Mr. Feng Zhou
Headquarters
Taizhou
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of China SXT Pharmaceuticals Inc - ADR stood at $ 23 Mln as on 31-Mar-24
The share price of China SXT Pharmaceuticals Inc - ADR is $2.08 (NASDAQ) as of 22-Apr-2025 16:29 EDT. China SXT Pharmaceuticals Inc - ADR has given a return of -24.72% in the last 3 years.
China SXT Pharmaceuticals Inc - ADR has a market capitalisation of $ 14 Mln as on 22-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/E ratio of China SXT Pharmaceuticals Inc - ADR is 0.01 times as on 22-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the China SXT Pharmaceuticals Inc - ADR and enter the required number of quantities and click on buy to purchase the shares of China SXT Pharmaceuticals Inc - ADR.
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China. Address: 178 North Taidong Road, Taizhou, China, 225300
The CEO & director of Mr. Feng Zhou. is China SXT Pharmaceuticals Inc - ADR, and CFO & Sr. VP is Mr. Feng Zhou.
There is no promoter pledging in China SXT Pharmaceuticals Inc - ADR.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| China SXT Pharmaceuticals Inc. - ADR | Ratios |
|---|---|
|
Return on equity(%)
|
-21.65
|
|
Operating margin(%)
|
-132.45
|
|
Net Margin(%)
|
-160.67
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of China SXT Pharmaceuticals Inc - ADR was No Profit.
$1.06
(
